Anthroposophic therapy for migraine: a two-year prospective cohort study in routine outpatient settings.

Simple item page
dc.contributor.authorHamre, Harald
dc.contributor.authorWitt, Claudia M.
dc.contributor.authorKienle, Gunver
dc.contributor.authorGlockmann, Anja
dc.contributor.authorZiegler, Renatus
dc.contributor.authorRivoir, Andreas
dc.contributor.authorWillich, Stefan N.
dc.contributor.authorKiene, Helmut
dc.date.accessioned2025-02-07T13:57:35Z
dc.date.available2025-02-07T13:57:35Z
dc.date.issued2010
dc.description.abstractBackground and Methods: Anthroposophic treatment for migraine is provided by physicians and includes special artistic and physical therapies and special medications. We conducted a prospective cohort study of 45 consecutive adult outpatients (89% women) starting anthroposophic treatment for migraine under routine conditions. Main outcomes were Average Migraine Severity (physician and patient ratings 0-10, primary outcome), Symptom Score (patient rating, 0-10), and quality of life (SF-36); main follow-up time point was after six months. Results: The anthroposophic treatment modalities used were medications (67% of patients), eurythmy therapy (38%), art therapy (18%), and rhythmical massage therapy (13%). Median therapy duration was 105 days. In months 0-6, conventional prophylactic antimigraine medications were used by 14% (n=5/36) of evaluable patients. From baseline to six-month follow-up, physician-rated Average Migraine Severity improved by 3.14 points (95% confidence interval 2.40-3.87, p<0.001); patient-rated Average Migraine Severity improved by 2.82 points (2.05-3.64, p<0.001); and Symptom Score improved by 2.32 points (1.68-2.95, p<0.001). In addition, three SF-36 scales (Social Functioning, Bodily Pain, Vitality), the SF-36 Physical Component summary measure, and the SF-36 Health Change item improved significantly. All improvements were maintained at last follow-up after 24 months. Patients not using conventional prophylactic antimigraine medications had improvements similar to the whole cohort. Conclusions: Patients with migraine under anthroposophic treatment had long-term improvement of symptoms and quality of life. Although the pre-post design of the present study does not allow for conclusions about comparative effectiveness, study findings suggest that anthroposophic therapies may be useful in the long-term care of patients with migraine. Keywords: Anthroposophy, combined modality therapy, drug therapy, eurythmy therapy, migraine, prospective studies.
dc.identifier.citationHamre, H. J., Witt, C. M., Kienle, G. S., Glockmann, A., Ziegler, R., Rivoir, A., Willich, S. N., & Kiene, H. (2010). Anthroposophic Therapy for Migraine: A Two-Year Prospective Cohort Study in Routine Outpatient Settings. 4(1). https://doi.org/10.2174/1874205X01004010100
dc.identifier.doihttps://doi.org/10.2174/1874205x01004010100
dc.identifier.issn1874-205X
dc.identifier.orcidhttps://orcid.org/0000-0003-1098-1079
dc.identifier.other21673981
dc.identifier.urihttps://hdl.handle.net/20.500.14430/763
dc.language.isoen
dc.relation.urlhttps://www.ifaemm.de/publikationen/
dc.subjectAnthroposophy
dc.subjectcombined modality therapy
dc.subjectdrug therapy
dc.subjecteurythmy therapy
dc.subjectmigraine
dc.subjectprospective studies.
dc.titleAnthroposophic therapy for migraine: a two-year prospective cohort study in routine outpatient settings.
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleOpen Neurology J
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Hamre_Anthroposophic Therapy for Migraine_2010.pdf
Size:
305.46 KB
Format:
Adobe Portable Document Format
Download
Collections
01 Anthroposophic medicine (AM), therapies and health